According to India's state owned Pharmaceutical Export Promotion Council’s year-end report, pharma exports from the country are expected to reach $19.1 billion during the current fiscal year -- despite muted growth in the North American markets -- a growth of 10.72 percent over $17.28 billion in pharma exports last year....
Biocon India Receives US FDA Approval for Biosimilar
India's Bangalore-based Biocon Ltd is the country's first company to have a "biosimilar" approved in the U.S. for Roche’s drug Trastuzumab, marketed as Herceptin, and used in treating certain breast and stomach cancers. Kiran Mazumdar-Shaw, the company’s chairperson and managing director said, "This was the first biosimilar for Herceptin approved...